导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 8.53% | 349/1050 |
| 近一周 | -1.37% | 537/1104 |
| 近一月 | 2.16% | 36/1103 |
| 近一季 | 6.76% | 120/1092 |
| 近半年 | 3.84% | 353/1070 |
| 近一年 | 12.85% | 336/1018 |
| 近两年 | 35.50% | 635/926 |
| 近三年 | 12.46% | 579/834 |
| 成立以来 | 55.42% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.25% 249/1070 |
-7.92% 863/1101 |
- - |
- - |
| 2025 | 3.40% 905/1065 |
-0.71% 843/1014 |
1.46% 555/1038 |
-2.67% 1023/1050 |
5.45% 120/1065 |
| 2024 | 3.56% 483/1011 |
-2.36% 439/960 |
-1.54% 409/983 |
9.73% 639/991 |
-1.83% 435/1011 |
| 2023 | 2.83% 62/952 |
9.32% 134/880 |
1.09% 128/895 |
-3.72% 237/915 |
-3.36% 362/952 |
| 2022 | -11.23% 99/867 |
-8.32% 74/773 |
4.11% 576/806 |
-7.05% 111/845 |
0.06% 443/867 |
| 2021 | 5.51% 296/740 |
3.06% 79/580 |
2.18% 508/659 |
-1.71% 249/704 |
1.93% 357/740 |
| 2020 | 8.22% 401/554 |
-9.31% 375/419 |
5.66% 413/466 |
7.15% 317/517 |
5.40% 430/554 |
| 2019 | 19.03% 333/410 |
13.45% 1023/1149 |
-1.32% 471/1231 |
-0.10% 334/390 |
6.43% 299/410 |
| 2018 | -16.00% 33/349 |
- - |
- - |
- - |
-7.00% 105/1080 |
| 2017 | 19.44% 84/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇丰晋信大盘波动股票C VS. 东吴新产业精选股票A(580008) |